0001104659-15-064510.txt : 20150910 0001104659-15-064510.hdr.sgml : 20150910 20150910132658 ACCESSION NUMBER: 0001104659-15-064510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150806 FILED AS OF DATE: 20150910 DATE AS OF CHANGE: 20150910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SteadyMed Ltd. CENTRAL INDEX KEY: 0001619087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 BUSINESS PHONE: 972-3-6449556 MAIL ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cermak Elizabeth CENTRAL INDEX KEY: 0001471971 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36889 FILM NUMBER: 151100789 MAIL ADDRESS: STREET 1: 1414 RALEIGH ROAD STREET 2: SUITE 400 CITY: CHAPEL HILL STATE: NC ZIP: 27517 4 1 a4.xml 4 X0306 4 2015-08-06 0 0001619087 SteadyMed Ltd. STDY 0001471971 Cermak Elizabeth C/O STEADYMED THERAPEUTICS, INC. 2603 CAMINO RAMON, SUITE 350 SAN RAMON CA 94583 1 0 0 0 Stock Option (Rt to Buy) 5.60 2015-08-06 4 A 0 33350 0.00 A 2025-08-06 Ordinary Shares 33350 33350 D 1/3rd of the option shares shall vest on the first anniversary of the grant date. Thereafter, the remaining balance of the option shares shall vest in a series of 8 equal consecutive quarterly installments until fully vested. /s/Michael E. Tenta, Attorney-In-Fact 2015-09-09 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Jonathan M.N. Rigby, David W. Nassif and Michael E. Tenta, signing individually, the undersigned’s true and lawful attorneys-in fact and agents to:

 

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of SteadyMed Ltd. (the “Company”), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder and a Form ID, Uniform Application for Access Codes to File on EDGAR;

 

(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

 

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company or Cooley LLP.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June 17, 2015.

 

 

/s/ Elizabeth Cermak

 

ELIZABETH CERMAK